In an earlier small-scale study, we found genes COPS3 in 17p11.2 and PMP22 in 17p12 to be most consistently overexpressed after amplification in osteosarcomas, making these genes candidate oncogenes in that segment [14]. The gene discussed is PMP22; the disease is osteosarcoma.